FEDI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 6.243
EU - Europa 5.076
AS - Asia 719
AF - Africa 37
OC - Oceania 2
SA - Sud America 2
Totale 12.079
Nazione #
US - Stati Uniti d'America 6.230
PL - Polonia 1.980
RU - Federazione Russa 1.154
IE - Irlanda 443
SE - Svezia 415
UA - Ucraina 343
IT - Italia 264
SG - Singapore 226
DE - Germania 221
HK - Hong Kong 198
FI - Finlandia 116
GB - Regno Unito 77
IN - India 75
TR - Turchia 73
CN - Cina 70
JO - Giordania 33
FR - Francia 32
VN - Vietnam 31
CI - Costa d'Avorio 21
SC - Seychelles 16
CH - Svizzera 14
CA - Canada 12
JP - Giappone 7
AT - Austria 4
KR - Corea 4
NL - Olanda 4
CZ - Repubblica Ceca 3
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
EE - Estonia 1
ES - Italia 1
HU - Ungheria 1
LT - Lituania 1
MX - Messico 1
TH - Thailandia 1
UZ - Uzbekistan 1
Totale 12.079
Città #
Warsaw 1.980
Santa Clara 1.040
Fairfield 767
Jacksonville 540
Chandler 479
Dublin 443
Ashburn 350
Woodbridge 345
Seattle 341
Wilmington 292
Cambridge 276
Houston 268
Singapore 180
Hong Kong 118
Princeton 109
Ann Arbor 101
Boardman 95
Boston 87
Altamura 75
Mumbai 64
Lawrence 61
Buffalo 46
Medford 39
Moscow 28
Shanghai 28
San Diego 24
Dong Ket 22
Izmir 22
Abidjan 21
Kent 21
Beijing 20
Frankfurt Am Main 20
Hillsboro 20
Milan 20
Auburn Hills 19
Norwalk 18
Florence 16
Andover 14
New York 14
Falls Church 13
Los Angeles 13
Phoenix 13
Bern 12
Verona 12
West Jordan 12
London 10
Salerno 10
Helsinki 8
Yubileyny 8
Toronto 7
Chicago 6
Fuzhou 5
Munich 5
Hanover 4
Tappahannock 4
Vienna 4
Brno 3
Detroit 3
Frankfurt am Main 3
Laurel 3
Redmond 3
Seoul 3
Atessa 2
Bremen 2
Brussels 2
Chiswick 2
Dearborn 2
Leicester 2
New Bedfont 2
North Bergen 2
Palermo 2
Philadelphia 2
Prato 2
Pune 2
Romola 2
Tokyo 2
Washington 2
Acton 1
Avezzano 1
Azcapotzalco 1
Bangkok 1
Brisbane 1
Budapest 1
Carate Brianza 1
Chiusdino 1
Colle Di Val D'elsa 1
Dallas 1
Düsseldorf 1
Edinburgh 1
Glasgow 1
Grevenbroich 1
Hanoi 1
Kunming 1
Lachine 1
Latina 1
Madrid 1
Manchester 1
Mcallen 1
Melbourne 1
Messina 1
Totale 8.640
Nome #
Protein Z gene polymorphisms (intron F 79G>A; -13 A>G) are not associated with acute coronary syndromes 269
Low protein Z levels in patients with peripheral arterial disease 259
A meta-analysis of potential risks of of low levels of protein Z for diseases related to vascular thrombosis 259
High lipoprotein (a) levels are associated with an increased risk of retinal vein occlusion 243
Fish intake and LPA 93C>T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations 239
Protein Z is not synthesised by human umbilical vein endothelial cells 236
Modifications of protein Z and interleukin-6 during the acute phase of coronary artery disease 234
Homocysteine and tissue factor pathway inhibitor levels in patients with Fabry's disease 233
Lower homocysteine levels in renal transplant recipients treated with everolimus: a possible link with a decreased cardiovascular risk? 229
Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome. 229
Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events. 226
Angiotensi-converting enzyme DD genotype, angiotensin type 1 receptor CC genotype, and hyperhomocysteinmeia increase first-trimester fetal-loss susceptibility 220
Evaluation of traditional and emerging cardiovascular risk factors in patients with non-arteritic anterior ischemic optic neuroparty: a case-control study 216
Thrombotic events in high risk patients are predicted by evaluating different pathways of platelet function. 207
Protein Z: "Light and Shade" of a new thrombotic factor 199
D-dimer concentrations during normal pregnancy, as measured by ELISA 152
D-Dimer in intra-uterine growth retardation and gestational hypertension 151
ACE DD genotype: an independent predisposition factor to venous thromboembolism. 132
D-dimer increase after percutaneous transluminal angioplasty and clinical recurrence after primary revascularization in acute myocardial infarction? A pilot study 128
D-dimer plasma levels during normal pregnancy measured by specific ELISA 127
Hyperhomocysteinemia in renal transplant patients as independent cause of endothelial damage and cardiovascular disease. 125
Protein Z plasma levels in different phases of activity of coronary atherosclerosis 125
Activation of the immune system and coronary artery disease: the role of anti-endothelial cell antibodies. 124
Blood clotting activation during normal pregnancy 124
Antiphospholipid antibodies (aPL) increase the potential monocyte procoagulant activity in patients with systemic lupus erythematosus 122
RISK FACTORS FOR CARDIOVASCULAR DISEASE IN RENAL TRANSPLANT RECIPIENTS: NEW INSIGHTS 120
Is tissue factor pathway inhibitor a marker of procoagulable status in healthy infertile women undergoing ovarian stimulation for assisted reproduction? 120
EFFECT OF TOURNIQUET USE ON ACTIVATION OF COAGULATION IN TOTAL KNEE REPLACEMENT 118
Electrophysiologic procedures and activation of the hemostatic system 118
Evaluation of clotting and fibrinolytic activation after protracted physical exercise 117
Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion 117
Usefulness of screening for congenital or acquired hemostatic abnormalities in women with previous complicated pregnancies. 115
A proinflammatory state is associated with hyperhomocysteinemia in the elderly 115
Platelet and blood clotting activation in patients with mitral valve prolapse 115
Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients. 114
Thrombophilias as risk factors for disorders of pregnancy and fetal damage 114
Antiphospholipid antibodies and pregnancy disorders in women with insulin dependent diabetes 113
Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. 112
Fibrinolysis alterations in infertile women during controlled ovarian stimulation: Influence of BMI and genetic components. 112
Angiotensin converting enzyme DD genotype affects the changes of plasma plasminogen activator inhibitor-1 activity after primary percutaneous transluminal coronary angioplasty in acute myocardial infarction patients 111
A hypercoagulable and hypofibrinolytic state is detectable by global methods in patients with retinal vein occlusion. 111
Effect of temperature and incubation time on D-dimer serum levels in healthy subjects. 109
TISSUE FACTOR AND HOMOCYSTEINE LEVELS IN ISCHEMIC HEART DISEASE ARE ASSOCIATED WITH ANGIOGRAPHICALLY DOCUMENTED CLINICAL RECURRENCES AFTER CORONARY ANGIOPLASTY 108
Influence of endothelial nitric oxide synthase gene polymorphisms (G894T, 4a4b, T-786C) and hyperhomocysteinemia on the predisposition to acute coronary syndromes 108
Increased plasma levels of lipoprotein(a) and the risk of idiopathic and recurrent venous thromboembolism 108
Clottable to immunological fibrinogen ratio in plasma from control subjects and hyperfibrinogenemic patients 106
Percutaneous transluminal coronary angioplasty procedure is associated to a decrease in transforming growth factor beta 1 levels 106
FIBRINOLYTIC PARAMETERS IN YOUNG ADULTS: THE FLOREN-TEEN ( FLORENCE TEENAGER) STUDY 105
Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients 105
Leisure-time but not occupational physical activity significantly affects cardiovascular risk factors in an adult population 105
Comparison of different methods to evaluate the effect of aspirin on platelet function in high-risk patients with ischemic heart disease receiving dual antiplatelet treatment. 104
The role of cysteine and homocysteine in venous and arterial thrombotic disease. 101
The influence of smoking on von Willebrand factor is already manifest in healthy adolescent females: the Floren-teen (Florence Teenager) Study. 101
Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion 101
Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration. 100
Relatioship between the platelet aggregation of the newborn and mother 98
Protein Z levels and prognosis in patients with acute coronary syndromes 96
Hyperhomocysteinemia and hypercoagulability in primary biliary cirrhosis. 96
Molecular mechanism underlying impaired platelet responsiveness in liver cirrhosis 95
Alterations of haemorheological parameters in patients with Peripheral Arterial Disease 94
Tissue factor reduction and tissue factor pathway inhibitor release after heparin administration. 94
Thrombophilic risk factors in patients with severe carotid atherosclerosis 93
Plasma and serum levels of D-dimer and their correlations with other hemostatic parameters in pregnancy. 93
Thrombophilic risk factors in patients with central retinal vein occlusion. 92
A mixture of bupivacaine and fentanyl in epidural block in orthopedic surgery: effects on blood coagulation and fibrinolysys 92
High prevalence of mild hyperhomocysteinemia in patients with abdominal aortic aneurysm 92
Homocysteine-lowering therapy and carotid intima-media thickness in renal transplant recipients. 91
Changes in lipid and hemostatic parameters induced by tibolone treatment 91
Activation of the coagulation system during electrophysiologic invasive study with and without ablation 91
Hemostatic disorders in 25 patients with limited and uncomplicated thyroid and breast cancer: prophylactic and therapeutic considerations 90
Anticoagulant effect of dabigatran, rivaroxaban or apixaban treatment on different laboratory hemostasis tests in patients with atrial fibrillation 90
Relevance of post-methionine homocysteine and lipoprotein (a) in evaluating the cardiovascular risk in young CAD patients. 89
TAFI activity and antigen plasma levels are not increased in acute coronary artery disease patients admitted to a coronary care unit 89
Acquired activated protein C resistance in postmenopausal women is dependent on factor VIII:c levels. 88
Hyperhomocysteinemia in patients with pulmonary embolism is associated with impaired plasma fibrinolytic capacity 87
D-dimer plasma levels in pathological pregnancy: use of a rapid test (NycoCard). 86
Antiphospholipid antibodies : a new risk factor for restenosis after percutaneous transluminal coronary angioplasty? 86
Low protein Z levels are independently associated with acute coronary syndromes 85
Evaluation of the prevalence of severe hyperhomocysteinemia in adult patients with thrombosis who underwent screening for thrombophilia 83
Hyperhomocysteinemia and vitamin B6 deficiency: new risk markers for nonvalvular atrial fibrillation? 82
Acute pyhase proteins in alcoholics with or without liver injury 82
Evaluation of a new point-of-care celite-activated clotting time analyzer in different clinical settings. The i-STAT celite-activated clotting time test. 81
Hyperhomocysteinemia in renal transplant patients: an independent factor of cardiovascular disease 81
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 79
Coparison of some serum copper parameters in treined runners and control subjects 78
High prevalence of anti-beta2 glycoprotein I antibodies in patients with ischemic heart disease 78
Dietary habits, lifestyle and cardiovascular risk factors in a clinically healthy Italian population: the “Florence” diet is not Mediterranean 77
High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism. 75
Nuovi fattori di rischio per la patologia carotidea 72
Changes in fibrinolysis after primary PTCA 71
Accuracy of a Point-of-Care system for PT/INR test performed in the hospital anticoagulation clinic 70
Hypofibrinolysis accounts only in part for alteration of clot lysis time in patients with prior pulmonary embolism without pulmonary hypertension 69
Protein Z levels, protein Z G79A polymorphism, and prothrombotic conditions 65
Omocisteina e malattie cerebrovascolari 64
Persistent generation of thrombin after coronary angioplasty 62
Substance P-induced fibrinolysis in teh forearm of healthy humans 61
Postprocedural PAI-activity is a risk marker of subsequent clinical restenosis in patients both with and without stent implantation after elective baloon PTCA 59
Procedure-dependence and tissue factor-indipendence of hypercoagulability during orthopaedic surgery 59
Hyperhomocysteinemia and abdominal aortic aneurysm 59
Iperomocisteinemia in pazienti con aneurisma dell’aorta addominale: nuovo fattore patogenetico? 58
Totale 11.780
Categoria #
all - tutte 29.594
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.594


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.574 0 0 0 0 233 290 206 310 193 108 198 36
2020/20211.387 104 102 123 167 39 180 55 153 82 201 42 139
2021/2022724 26 55 63 30 36 29 14 48 32 37 165 189
2022/20231.822 177 246 69 163 183 350 258 106 185 7 51 27
2023/2024602 35 73 117 30 32 87 26 134 2 15 32 19
2024/20252.799 122 467 266 671 1.273 0 0 0 0 0 0 0
Totale 12.142